identified a novel ROS/KEAP1/NRF2 pathway through which curcumin modulates the expression of miR‐34a/b/c in colorectal cancer (CRC) cells, subsequently reducing metastatic potential and enhancing apoptosis (Liu et al. 2023). The gene discussed is KEAP1; the disease is colorectal carcinoma.